Imaging of gliomas with Cis-4-[18F]fluoro-L-proline

Nucl Med Biol. 2004 Jan;31(1):67-75. doi: 10.1016/s0969-8051(03)00121-5.

Abstract

Tumor imaging with cis-4-[18F]fluoro-L-proline (cis-FPro) was compared to that of L-[3H]proline and L-[3H]methionine in F98 rat gliomas by dual-tracer autoradiography. All tracers exhibited high accumulation in the tumors but in the normal brain significant uptake was observed for L-[3H]methionine only. Tumor extent on autoradiograms with L-[3H]proline and L-[3H]methionine was identical to that of histological staining while autoradiograms of cis-FPro showed diffuse uptake in the penumbra of some tumors. First PET studies in 7 patients with cerebral gliomas demonstrated accumulation of cis-FPro in tumor areas with enhancement of Gd-DTPA on MR scans. Uptake of cis-FPro in normal brain tissue was negligible. In one patient with a glioblastoma accumulation of cis-FPro was also found in two brain areas without enhancement of Gd-DTPA on MR scans. Control of MRI suggested tumor growth in these areas at further follow up. Our results indicate that in most gliomas increased cis-FPro uptake is restricted to areas with disruption of the BBB which limits its clinical utility.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adult
  • Animals
  • Autoradiography
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / diagnostic imaging*
  • Cell Line, Tumor
  • Female
  • Glioma / diagnosis
  • Glioma / diagnostic imaging*
  • Humans
  • Male
  • Methionine / analogs & derivatives*
  • Middle Aged
  • Proline* / analogs & derivatives
  • Radiopharmaceuticals
  • Rats
  • Rats, Inbred F344
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tomography, Emission-Computed / methods*

Substances

  • Radiopharmaceuticals
  • fluoro-proline
  • Proline
  • Methionine
  • methionine methyl ester